🕵️ Fibrobiologics, Inc. ($FBLG)
SEC insider & ownership activity, last 12 months · CIK 1958777 · every row links its SEC filing
Over the last 12 months insiders bought $121K with no open-market selling against it. Ruben A. Garcia bought $61K in discretionary trades (Dec–Feb). One red-flag 8-K in the window: Delisting notice (3.01), Jul 22, 2026.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
4 buyers, $121K (7 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Ruben A. Garcia | 2 | $61K | 0 | – | Feb 27, 2026 |
| Davis Jason | 1 | $29K | 0 | – | Mar 2, 2026 |
| O'Heeron Pete | 3 | $20K | 0 | – | Mar 4, 2026 |
| Khoja Hamid | 1 | $11K | 0 | – | Mar 4, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Pete O'Heeron | 18.2% | 13G | Feb 12, 2025 | filing ↗ | |
| Armistice Capital, LLC | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Steven Boyd | 10.0% | 13G | Aug 14, 2026 | filing ↗ | |
| Mike Newlin | 5.6% | 13G | Jun 6, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Material agreement (1.01) | Sep 15, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Sep 15, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 15, 2026 | filing ↗ |
| Officer/director changes (5.02) | Aug 20, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Aug 20, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 20, 2026 | filing ↗ |
| Delisting notice (3.01) | Jul 22, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jul 2, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jul 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jul 2, 2026 | filing ↗ |
| Material agreement (1.01) | Jun 25, 2026 | filing ↗ |
| Unregistered equity sale (3.02) | Jun 25, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 25, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 25, 2026 | filing ↗ |
| Officer/director changes (5.02) | Jun 22, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 22, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 22, 2026 | filing ↗ |
| Material agreement (1.01) | May 5, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 5, 2026 | filing ↗ |
| Officer/director changes (5.02) | May 4, 2026 | filing ↗ |
| Material agreement (1.01) | May 1, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 1, 2026 | filing ↗ |
| Charter/bylaw changes (5.03) | Apr 16, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 16, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 3, 2026 | filing ↗ |
| Agreement terminated (1.02) | Apr 3, 2026 | filing ↗ |
| Other events (8.01) | Apr 3, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Apr 3, 2026 | filing ↗ |
| Material agreement (1.01) | Apr 3, 2026 | filing ↗ |
| Other events (8.01) | Apr 3, 2026 | filing ↗ |